46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

8 trials found

diseases per page:

Showing 1 to 8 of 8 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1900027855	2019-11-29	2019-11-30	Pharmacokinetics of CYP2C9 * 3 homozygous mutant subjects in a single oral meloxicam tablet	Pharmacokinetics of CYP2C9 * 3 homozygous mutant subjects in a single oral meloxicam tablet	Osteoarthritis, rheumatoid arthritis	Case:Meloxicam 15mg;	Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University	NULL	Pending	18	45	Male	Case:1;	Phase 1	China
2	ChiCTR1900025021	2019-07-25	2019-08-07	Safety, Tolerance and Pharmacokinetics of Single Administration of MeloxicamSuspension Injection in ...	Safety, Tolerance and Pharmacokinetics of Single Administration of MeloxicamSuspension Injection in ...	Osteoarthritis, rheumatoid arthritis	A:TR group: phase I: MeloxicamSuspension Injection (T) 7.5 mg, phase II: Mobi (R) 7.5 mg; RT group: ...	Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University	NULL	Recruiting			Both	A:12;B:12;C:12;D:12;	Phase 1	China
3	NCT00239382 (ClinicalTrials.gov)	July 1, 2004	13/10/2005	A Study to Compare MeloxicamIM Once Daily Versus MeloxicamOrally Once Daily in Patients With Rheumat ...	A Randomized, Open-labelled Study to Compare the Efficacy and Safety of Meloxicam15 mg IM Ampoules O ...	Arthritis, Rheumatoid	Drug: Meloxicam ampoule;Drug: Meloxicam tablet	Boehringer Ingelheim	NULL	Completed	18 Years	N/A	All	150	Phase 3	China
4	NCT02184052 (ClinicalTrials.gov)	July 2003	3/7/2014	Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Os ...	Meloxicam (MOBIC®) Ampoule Post Marketing Surveillance Study	Arthritis, Rheumatoid	Drug: Meloxicam	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	121	N/A	NULL
5	NCT00042068 (ClinicalTrials.gov)	June 2002	22/7/2002	A Multi-Center Trial to Compare Three Doses of Meloxicamand Placebo in Patients With Rheumatoid Arth ...	A Multi-center, Double-Blind, Randomized, Parallel-Group Trial to Compare the Efficacy and Safety of ...	Arthritis, Rheumatoid	Drug: Meloxicam	Boehringer Ingelheim	NULL	Completed	18 Years	80 Years	Both	1000	Phase 3	United States;Argentina;Australia;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Korea, Republic ...
6	NCT02180516 (ClinicalTrials.gov)	October 2001	1/7/2014	Safety and Efficacy of MeloxicamCompared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an ...	Safety and Efficacy of Meloxicam(MOBIC) Compared to Other NSAIDs in Approved Therapeutic Dosages and ...	Arthritis, Rheumatoid	Drug: Meloxicam;Drug: Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	9984	N/A	NULL
7	NCT00034853 (ClinicalTrials.gov)	December 2000	2/5/2002	Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)	A 12 Week Double-blind Randomized Trial, With a 12 Week Open-label Extension, to Investigate the Eff ...	Arthritis, Juvenile Rheumatoid	Drug: meloxicam oral suspension;Drug: naproxen oral suspension	Boehringer Ingelheim	NULL	Completed	2 Years	17 Years	Both	180	Phase 3	United States;Brazil;Mexico;Ukraine;Argentina
8	NCT00279747 (ClinicalTrials.gov)	September 2000	19/1/2006	A One Year Double-blind Trial to Investigate the Efficacy and Safety of MeloxicamOral Suspension in ...	A One Year Double-blind Trial to Investigate the Efficacy and Safety of MeloxicamOral Suspension 0.2 ...	Arthritis, Juvenile Rheumatoid	Drug: meloxicam 0.25 mg/kg;Drug: meloxicam 0.125 mg/kg;Drug: naproxen 10 mg/kg	Boehringer Ingelheim	NULL	Completed	2 Years	16 Years	Both	226	Phase 3	Austria;Belgium;France;Germany;Italy;Russian Federation;United Kingdom

First Previous1Next Last